前收市價 | 21.45 |
開市 | 21.42 |
買盤 | 0.00 x 1800 |
賣出價 | 0.00 x 3100 |
今日波幅 | 21.05 - 21.58 |
52 週波幅 | 21.05 - 42.29 |
成交量 | |
平均成交量 | 11,275,283 |
市值 | 18.232B |
Beta 值 (5 年,每月) | 0.69 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -3.84 |
業績公佈日 | 2023年10月12日 |
遠期股息及收益率 | 1.92 (8.79%) |
除息日 | 2023年8月18日 |
1 年預測目標價 | 31.85 |
If you’re struggling to afford prescriptions, GoodRx’s deal with Walgreens could help. Prices on nearly 200 medications will be cut by an average of 40%, and many can be bought for under $15 for a 30-day fill. If you're one of the many Americans struggling to afford prescription medication, GoodRx's deal with Walgreens could help you save the next time you're at the pharmacy. Prices on nearly 200 prescription medications will now be discounted by an average of 40%, and many prescriptions can now
Roz Brewer joined Walgreens Boots Alliance (NASDAQ:WBA) as its chief executive officer (CEO) with great fanfare in January 2021. “The Board conducted an extensive search to identify an exceptional leader who will build on WBA’s track record of success and take advantage of the many growth opportunities in many markets across the company. We are excited to have found that person in Roz,” said Stefano Pessina, the business’ largest shareholder. On Sept. 1, Brewer stepped down as CEO and board memb
The healthcare deal aims to help Walgreens grow its community-based primary care services. Walgreens is expanding further into value-based healthcare by partnering with Pearl Health, a startup technology firm and the retail pharmacy’s latest initiative to grow its community-based primary care services.Pearl is focused on primary care physicians transitioning away from fee-for-service compensation to value-based payments with the aim of reducing the total cost of care. The tech firm promotes Acco